Journal Club

JOURNAL CLUB (MANDATORY)

Usually monthly on the last Tuesday from 12:15-1:15 pm in 13-126 CSB and via Zoom

Journal Club Expectations of the SSR and the Staff Preceptor

These rounds are intended to:

• Provide the trainees of Medical Microbiology and Pediatric and Adult Infectious Diseases with additional experience in presenting and critical appraisal

• Keep divisional members aware of different aspects of a broad variety of literature which they may not otherwise encounter

Articles

• • A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis (January 17, 2023)

  • A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated with Empiric Broad-Spectrum Antibiotics with in Critically Ill Patients (May 16, 2023)

  • A Selective Antibiotic for Lyme Disease (December 16, 2021)

  • Association of Repeated Blood Cultures With Mortality in Adult Patients with Gram-Negative Bacilli Bacteremia: A Systemic Review and Meta-Analysis (July 18, 2023)

  • Breastfeeding Among People with HIV in North America: A Multisite Study (June 13, 2023)

  • Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial (April 23, 2024)

  • Colistin Monotherapy Versus Combination Therapy for carbapenem-Resistant Organisms (February 14, 2023)

  • Discontinuing B-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC):  double-blind, randomised, placebo-controlled, non-inferiority trial (September 23, 2021)

  • Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States (September 22, 2022)

  • Effectiveness of a tailored intervention to reduce antibiotics for urinary traction infections in nursing home residents: a cluster, randomised controlled trial (July 28, 2022)

  • Effectiveness of different antimicrobial strategies for staphylococcal prosthetic joint infections: results from a large prospective registry-based cohort study. (October 6, 2022)

  • Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue. NEJM June 2021. (November 25, 2021)

  • Impact of Systematic Whole-Body F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. (October 28, 2021)

  • "Discontinuation of Contact Precautions on Surveillance and Whole Genome Sequencing-Defined Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections" (July 30, 2024)

  • "Impact of Treatment on Long-Term Survival of Patients with Mycobacterium avium Complex Pulmonary Disease" (August 29, 2023)

  • Infective Endocarditis Among High-Risk Individuals Before and After the Cessation of Antibiotic Prophylaxis in Dentistry: A National Cohort Study (November 15, 2022)

  • Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia (January 30, 2024)

  • Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19 (June 16, 2022)

  • Longitudinal Analysis Reveals High Prevalence of Epstein-Barr Virus Associated with Multiple Sclerosis (March 31, 2022)

  • Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial (February 24, 2022)

  • Oral B-Lactams, Fluoroquinolones, or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Uncomplicated Escherichia coli or Klebsiella Species Bacteremia from a Urinary Tract Source (March 26, 2024)

  • Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection - (May 26, 2022)

  • Outcomes of Partial Oral Antibiotic Treatment Complicated Staphylococcus Aureus Bactermia in People Who Inject Drugs - (December 14, 2022)

  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections - (April 18, 2023)

  • Randomized Trial of Amoxicillin for Pneumonia in Pakistan (August 25, 2022)

  • Safety & efficacy of antibiotic de-escalation & discontinuation in high-risk haematological patients with febrile neutropenia: a single-centre experience (January 27, 2022)

  • SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection (November 28, 2023)

  • Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis (April 28, 2022)

  • Stewardship Prompts to Improve Antibiotic Selection for Urinary Tract Infection - The INSPIRE Randomized Clinical Trial (May 28, 2024)

  • The Short versus Long Antibiotic Course for Pleural Infection Management (SLIM) Randomised Controlled Open-Label Trial (February 19, 2024)

  • Treatment Strategy for Rifampin-Susceptible Tuberculosis (March 14, 2023)

Questions or concerns? Contact the Medical Education Program Coordinator at mednid@ualberta.ca